Joint Clinical Trials Office
Biochemical characterization of Parkinson's disease-related proteins in the enteric nervous system
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 8, 2020
Identifying mechanisms of tissues injury in MS lesions: a multi-modality imaging approach
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 8, 2020
Glucocorticoid Receptor Antagonism in the Treatment of Cushing Syndrome (GRACE): A Phase 3, Double-Blind, Placebo-Controlled, Randomized-Withdrawal Study of the Efficacy and Safety of Relacorilant
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 8, 2020
A Multipart, Open-label, Single-arm, Multicenter Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ELA026 in Participants with Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Study Status:
Open to Enrollment
Primary Investigator:
Date: February 6, 2026
Pathology and CT Microdosimetry of Eye90 Treated Hepatocellular Carcinoma
Study Status:
Open to Enrollment
Primary Investigator:
Date: May 11, 2026
The NYPH-Weill Cornell Medical Center Gastrointestinal Oncology Registry
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 14, 2020
The LUCINDA Trial
Study Status:
Open to Enrollment
Primary Investigator:
Date: July 16, 2020
Indications for Use of CD34 Selection Column (CliniMACS-Miltenyi Biotec)
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 12, 2020
A Multi-center Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adults Patients with Hematologic Malignancies and Other Indications
Study Status:
Open to Enrollment
Primary Investigator:
Date: August 12, 2020
REPOWER: "Real-world Evaluation of Patient Outcomes and Experiences with Ribociclib Early Adopters: A Hybrid Study with Prospective Patient-reported Outcomes and Retrospective Clinical Chart Review"
Study Status:
Open to Enrollment
Primary Investigator:
Date: May 29, 2026